Educational visiting and hypnosedative prescribing in general practice.
Public concern about the prescription of hypnosedative drugs (mostly benzodiazepines) led to a controlled trial of an educational intervention to promote rational prescribing by general practitioners (GPs). This paper describes the educational intervention and its process evaluation. In urban and rural New South Wales 137 GPs were visited in office hours by a GP or pharmacist who had undergone communication skills training. Material offered to GPs included relaxation tapes and a booklet of problem-orientated management guidelines. The interview had three stages: rapport was established, then educational material was introduced and finally the visitor sought the doctor's agreement to review five patients on long-term benzodiazepines. The visits were well received. Several measures were composed to reflect doctors' motivation and interest in non-drug management; there was virtually no correlation between any of these process measures and the trial outcome: a change in prescribing behaviour. Self-rating of benzodiazepine prescribing greatly underestimated actual self-reported incidents of prescribing. We interpret this as a reminder that we do not always do what we mean to do, and that we do not always do what we think we do.
Yeo
G T
GT
Eastern Sydney Health Area Health Service, Prince of Wales Hospital, Randwick, NSW, Australia.
de Burgh
S P
SP
Letton
T
T
Shaw
J
J
Donnelly
N
N
Swinburn
M E
ME
Phillips
S
S
Bridges-Webb
C
C
Mant
A
A
D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy*; D001291:Attitude of Health Personnel; D001569:Benzodiazepines; D011307:Drug Prescriptions; D004363:Drug Utilization; D004502:Education, Medical, Continuing; D005194:Family Practice / Q000193:education*; D005500:Follow-Up Studies; D006801:Humans; D007318:Inservice Training; D009517:New South Wales; D010353:Patient Education as Topic; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines